GlassScriptPhysician profile
Daniel J Larsen
NPI 1902867146
$2,894.67
in general payments reported to CMS, 2019-2025
14 companies · $597 in 2025
The $597 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $169 · 2021: $163 · 2022: $158 · 2023: $731 · 2024: $795 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,123.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,593.09 | 2019-2025 | Aveir, Gallant, Tacticath Ablation Catheter, Sensor Enabled |
| Medtronic, INC. | $505.33 | 2021-2024 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Mycarelink |
| Novartis Pharmaceuticals Corporation | $221.50 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $170.59 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $102.25 | 2021-2023 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $64.67 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.51 | 2023-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.93 | 2021-2023 | Jardiance |
| Boston Scientific Corporation | $27.71 | 2021 | |
| Cvrx, INC. | $25.74 | 2024 | Barostim Neo System |
| Biotronik INC. | $24.47 | 2020 | |
| Cardiva Medical, INC. | $24.32 | 2019 | |
| Irhythm Technologies, INC. | $17.47 | 2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $17.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Larsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.